Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-24 4:01 pm Purchase | 13G | Mineralys Therapeutics Inc. MLYS | Andera Partners | 2,865,976 7.000% | 2,865,976 (New Position) | View |
2022-10-20 08:54 am Purchase | 13G | CONTEXTLOGIC INC LOGC | Andera Partners | 2,287,413 7.200% | 499,500 (+27.94%) | View |
2021-02-12 4:37 pm Purchase | 13G | CONTEXTLOGIC INC LOGC | Andera Partners | 1,787,913 5.620% | 500 (+0.03%) | View |
2021-02-03 07:11 am Sale | 13D | Axonics Inc. AXNX | Andera Partners | 1,987,282 4.990% | -670,179 (-25.22%) | View |
2020-05-21 4:09 pm Sale | 13D | Axonics Inc. AXNX | Andera Partners | 2,657,461 6.800% | -300,000 (-10.14%) | View |
2020-02-05 06:46 am Sale | 13G | Verona Pharma plc VRNA | Andera Partners | 2,348,814 2.200% | -4,303,584 (-64.69%) | View |
2020-01-24 4:16 pm Sale | 13D | Axonics Inc. AXNX | Andera Partners | 2,957,461 8.700% | -300,000 (-9.21%) | View |
2019-12-03 4:30 pm Sale | 13D | Axonics Inc. AXNX | Andera Partners | 3,257,461 9.810% | -300,000 (-8.43%) | View |